Home » Topics » Regulatory » Patents

Patents
RSS

Oral antiinflammatory/analgesic compounds with reduced ulcerogenic potential

May 19, 1998

Helopharm describes improved class III antiarrhythmic agents

May 19, 1998

Antifungal agents disclosed by Nippon Soda

May 15, 1998

Novel isoquinolines prepared at Snow Brand Milk Products inhibit neuronal cell death

May 15, 1998

Banyu describes antimuscarinic piperidines with bronchodilating effects

May 14, 1998

Neuraminic acid derivatives claimed by Sankyo for influenza

May 14, 1998

Roche presents series with potent activity against HSV thymidine kinase

May 14, 1998

Na+/H+ exchange inhibitors claimed for ischemic and other disorders by Hoechst

May 14, 1998

Bis-imide antitumor agents developed at ADIR

May 14, 1998

New SERMs discovered at Lilly and claimed for estrogen-dependent disorders

May 13, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...
Chengdu Mfs Pharma synthesizes new compounds for pain
BioWorld Science
Chengdu Mfs Pharma Co. Ltd. has prepared and tested compounds for the potential treatment of pain, sleep disorder and status epilepticus epilepsy as well as for...